Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TruLite is a topical skin-brightening and lightening cream developed by VTS Life Sciences for cosmetic and dermatological use. The formulation is a combination of several active ingredients, including tetrahydrocurcumin, licorice extract, arbutin, kojic acid, niacinamide, soy isoflavone, tocopherol acetate (vitamin E), glycolic acid, and allantoin. Its primary mechanism of action is the inhibition of tyrosinase, the rate-limiting enzyme in melanin synthesis, which prevents the formation of melanin pigment. TruLite is indicated for the treatment of various skin conditions characterized by hyperpigmentation, such as freckles, post-acne dark spots, age spots, and acne scars. It is currently an approved product available in the Indian market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TruLite.